MarkBarryAbelsonMDDSc(hon)

PubMed

• Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials.
  John D Rodriguez, Samantha Kerti, Adam Hamm, George W Ousler, Ethan Bensinger
  Clinical Ophthalmology. 2024-01-01
• 1 citations
  Nine-year, single-centre experience of left atrial appendage occlusion: patient characteristics, procedural outcomes and long-term follow up.
  Mark Abelson, Andre Phillips, Shirley Middlemost
  Cardiovascular Journal of Africa. 2021-02-26
• 4 citations
  An exploratory study to evaluate visual function endpoints in non-advanced age-related macular degeneration
  Divya Narayanan, John David Rodriguez, Garrick Wallstrom, Donna Welch, Matthew Jonathan Chapin
  BMC Ophthalmology. 2020-10-22

Journal Articles

• Advances in pharmacotherapy for allergic conjunctivitis.  
  Abelson MB, Shetty S, Korchak M, Butrus SI, Smith LM., Expert Opin. Pharmacother., 6/1/2015
• Automated Grading System for Evaluation of Superficial Punctate keratitis Associated with Dry Eye.  
  Rodriguez JD, Lane KJ, Ousler III GW, Angjeli E, Smith LM, Abelson MB, Invest Ophthalmol Vis Sci, 4/1/2015
• Automated grading system for evaluation of ocular redness associated with dry eye  
  Rodriguez JD, Johnston PR, Ousler III GW, Smith LM, Abelson MB, Clinical Ophthalmology, 6/1/2013
• The interblink interval in normal and dry eye subjects  
  Johnston PR, Rodriguez J, Lane KJ, Ousler G, Abelson MB, Clinical Ophthalmology, 2/1/2013
• Investigation of extended blinks and interblink intervals in subjects with and without dry eye  
  Rodriguez JD, Ousler III GW, Johnston PR, Lane K, Abelson MB, Clinical Ophthalmology, 2/1/2013
• Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy  
  Gomes PJ, Ousler GO, Welch DL, Smith LM, Coderre J, Abelson MB, Clinical Ophthalmology, 1/1/2013
• Bepotastine Besilate Ophthalmic Solutions Study Group Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of aller...  
  Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ, McNamara TR, J Ocul Pharmacol Ther, 8/1/2011
• Bepotastine Besilate Ophpthalmic Solutions Clinical Study Group Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival ...  
  Torkildsen GL, Williams JI, Gow JA, Gomes PJ, Abelson MB, McNamara TR, Ann Allergy Asthma Immunol, 7/1/2010
• Bepotastine Besilate Ophthalmic Solutions Clinical Study Group Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 10% and 15% to treat allerg...  
  Macejko TT, Bergmann MT, Williams JI, Gow JA, Gomes PJ, McNamara TR, Abelson MB, Am J Ophthalmol, 7/1/2010
• Time to Onset and Duration of Action of the Antihistamine Bepotastine Besilate Ophthalmic Solutions 10% and 15% in Allergic Conjunctivitis: A Phase III, Single-Center,...  
  Abelson MB, Torkildsen GL, Williams JI, et al, Clin Ther, 9/1/2009
• The Ocular Protection Index  
  Ousler GW, Hagberg KW, Schindelar M, Welch D, Abelson MB., Cornea, 5/1/2008
• A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with ...  
  Abelson MB, Protzko E, Shapiro A, Graces-Soldana A, Bowman L, Clinical Ophthalmology, 1/1/2007
• Efficacy of Once-Daily Olopatadine 02% Ophthalmic Solution Compared to Twice-Daily Olopatadine 01% Ophthalmic Solution for the Treatment of Ocular Itching Induced by C...  
  Abelson MB, Spangler DL, Epstein AB, Mah FS, Crampton HJ, Current Eye Research, 1/1/2007
• Pharmacology, clinical efficacy and safety of olopatadine hydrochloride.  
  Lichtenstein SJ, Abelson MB., Expert Rev Clin Immunol 2006;2(3):341-351, 3/1/2006
• Effects of adjuvant therapy with 01% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy  
  Berger W, Abelson MB, Gomes PJ et al, Annals of Allergy, Asthma & Immunology, 10/1/2005
• Methodologies for the Study of Ocular Surface Disease  
  Ousler GW, Gomes PJ, Abelson MB et al, The Ocular Surface, 7/1/2005
• Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle- controlled environmental trial in patients with s...  
  Whitcup SM, Bradford R, Lue J, Schiffman RM, Abelson MB, Clin Ther, 1/1/2004
• An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride  
  Ousler GW, Wilcox KA, Gupta G, Abelson MB, Annals of Allergy, Asthma & Immunology, 1/1/2004
• Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.  
  Greiner JV, Mundorf T, Dubiner H, Lonsdale J, Casey R, Parver L, Kapik BM, Shams NB, Abelson MB, Am J Ophthalmol. 2003 Dec; 136(6):1097-1105., 12/1/2003
• Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatments with olopatadine in the conjunctival allergen challenge...  
  Leonardi A, Abelson MB., Clin Ther. 2003 Oct; 25(10):2539-52., 10/1/2003
• Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment.  
  Abelson MB, Smith L, Chapin M., The Ocular Surface 2003; 1(3):127-149, 7/1/2003
• Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.  
  Abelson MB, Chapin MJ, Kapik BM, Shams NB., Arch Ophthalmol 2003 May; 121(5):626-30., 5/1/2003
• Safety and efficacy comparison of emedastine 005% ophthalmic solution compared to levocabastine 005% ophthalmic suspension in pediatric subjects with allergic conjunct...  
  Secchi A, Ciprandi G, Leonardi A, Deschenes J, Abelson MB, Acta Ophthalmol Scand Suppl, 1/1/2000
• Current and Future Topical Treatments for Ocular Allergy.  
  Abelson MB, Chapiin MJ., Comprehensive Ophthalmology Update 1(5):303-320, 2000
• A Comparison of the Effects of Ketotifen Furmarate 005%, Dimethindene Maleate 005%, and Levocabastine Hydrochloride 005% in the Allergen Challenge Model of Allergic Co...  
  Abelson MB, Greiner JV, Chin TL, Ophthalmic Practice, 1/1/1999
• Join now to see all

Books/Book Chapters

• Alert & Jakobiec's Principles and Practice of Ophthalmology 
  Chapter: Corticosteroids in Ophthalmic Practice. 
  Page 249 - 258Abelson MB, Butrus S.Editors: Albert DM, Miller JW, Azar DT, Blodi BA.Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology. 
  Chapter: Nonsteroidal Anti-inflammatory Drugs. 
  Page 259 - 264To KW, Abelson MB, Neufeld AH.Editors: Albert DM, Miller JW, Azar DT, Blodi BA..Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology. 
  Chapter: Antihistamines and Mast Cell Stabilizers in Allergic Ocular Disease. 
  Page 265 - 280Berdy GJ, Leonardi A, Abelson MB.Editors: Albert DM, Miller JW, Azar DT, Blodi BA..Saunders Elsevier, Inc., PhiladelplhiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology. 
  Chapter: Tear Film and Blink Dynamics. 
  Page 281 - 286Abelson MB, Doane MG, Ousler G.Editors: Albert DM, Miller JW, Azar DT, Blodi BA..Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology. 
  Chapter: Tear Substitutes. 
  Page 287 - 292Abelson MB, Ousler G, Anderson R.Editors: Albert DM, Miller JW, Azar DT, Blodi BA..Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology. 
  Chapter: Allergic and Toxic Reactions: The Immune Response. 
  Page 611 - 624Abelson MB, Torkildsen GL, Udell IJ.Editors: Albert DM, Miller JW, Azar DT, Blodi BA..Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Albert & Jakobiec's Principles and Practice of Ophthalmology 
  Chapter: Ocular Pharmacokinetics. 
  Page 179 - 192Chun DK, Shapiro A, Abelson MBEditors: Albert DM, Miller JW, Azar DT, Blodi BA.Saunders Elsevier Inc., PhiladelphiaEdition 3rd,2008
• Allergy and Immunology An Otolaryngic Approach. 
  Chapter: Ocular Allergy 
  Page 291 - 312Abelson MB, Chapin MJ, Sandman ER.Editors: Krouse JH, Chadwick SJ, Gordon BR, Derebery MJ..Lippincott Williams & Wilkins, Philadelphia2002
• Ocular Allergies: A Clinical View to Management 
  Abelson MB, Raizman MB, Berdy GJ, Bonini S, Friedlaender MH, Fujishima H, Trocme SDThe Willow Group, Inc., Barrington, IL2000
• Principles and Practice of Ophthalmology 
  Chapter: Overview 
  Page 201 - 202Abelson MBEditors: Albert DM, Jakobiec FA.W.B. Saunders Co., Philadelphia2000
• Principles and Practice of Ophthalmology. 
  Chapter: Allergic and Toxic Reastions. 
  Page 781 - 803Abelson MB, Udell IJ.Editors: Albert DM, Jakobiec FA..W.B. Saunders Co., Philadelphia2000
• Principles and Practice of Ophthalmology 
  Chapter: Nonsteroidal LAnti-inflammatory Drugs. 
  Page 300 - 305To KW, Abelson MB, Neufeld AH.Editors: Albert DM, Jakobiec FA..W.B. Saunders Co., Philadelphia2000
• Principles and Practice of Ophthalmology 
  Chapter: Corticosteroids in Ophthalmic Practice. 
  Page 258 - 267Abelson MB, Butrus S.Editors: Albert DM, Jakobiec FA..W.B. Saunders Co., Philadelphia2000
• Principles and Practice of Ophthalmology. 
  Chapter: Tear Substitutes. 
  Page 325 - 330Nelson JC, Abelson MB.Editors: Albert DM, Jakobiec FA..W.B. Saunders Co., Philadelphia2000
• Textbook of Ocular Pharmacology 
  Chapter: Anti-Allergic Therapies 
  Abelson MB, McGarr PJ, Richard KP.Lippincott-Raven, New York, NY1996
• Principles and Practice of Ophthalmology 
  Chapter: Corticosteroids in Ophthalmic Practice 
  Page 1013 - 1022Abelson MB, Butrus S.Editors: Albert DM, Jakobiec FA.WB Saunders Co., Philadelphia1994
• Lacrimal Gland, Tear Film, and Dry Eye Syndromes 
  Chapter: A precise method of using rose bengal in the evaluation of dry eye and the detection of changes in its severity 
  Page 549 - 552George MA, Abelson MB, Schaefre K, Mooshian M, Weintraub D.Editors: Sullivan DA.Plenum Press, Adv Exp Med Biol, New York1994
• Proceedings of Levocabastine Investigator's Symposium 
  Chapter: The Efficacy of Levocabastine in the Antigen Challenge Model 
  Abelson MBIOLAB Corporation, Claremont, CA1994
• Principles and Practice of Ophthalmology 
  Chapter: Tear Substitutes. 
  Page 1055 - 1060Abelson MBEditors: Albert DM, Jakobiec FA.WB SAunders Co., Philadelphia1994
• Principles and Practice of Ophthalmology 
  Chapter: Nonsteroidal anti-inflammatory drugs 
  Page 1022 - 1027To K, Abelson MB, Neufeld A.Editors: Albert DM, Jakobiec FA.WB Saunders Co., Philadelphia1994
• Principles and Practice of Ophthalmology 
  Chapter: Sclera 
  Abelson MB, Wagoner MD, section editors.Editors: Albert DM, Jacobiec FA.WB Saunders Co., Philadelphia1994
• Principles and Practice of Ophthalmology 
  Chapter: Overview 
  Page 915 - 916Abelson MBEditors: Albert DM, Jacobiec FA.WB Saunders Co., Philadelphia1994
• Principles and Practice of Ophthalmology 
  Chapter: Pharmacokinetcs 
  Page 916 - 928Ueno N, Refojo MF, Abelson MBEditors: Albert DM, Jakobiec FA.WB Saunders Co., Philadelphia1994
• Principles and Practice of Ophthalmology 
  Chapter: Antihistamines and Mast Cell Stabilizers in Allergic Ocular Disease. 
  Page 1028 - 1042Berdy GJ, Abelson MB.Editors: Albert DM, Jakobiec FA.WB Saunders Co., Philadelphia1994
• Duane's Foundations of Clinical Ophthalmology 
  Chapter: Mediators of Ocular Inflammation 
  Page 1 - 10Abelson MB, Smith LM.Editors: Tasman W..JB Lippincott Co., Philadelphia1991
• Join now to see all

Abstracts/Posters

• Automated Analysis of Fluorescein Staining Response to Controlled Adverse Environment Exposure (CAE)
  Rodriguez JD, Angjeli E, Lane KJ, Ousler III GW, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/3/2015
• Alcaftadine 0.25% Ophthalmic Solution Demonstrates Fast and Long-Lasting Efficacy in the Prevention of Ocular Itch.
  Gomes P, Abelson MB, Welch D, Torkildsen G, Shedden A., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• A Pilot Study Evaluating Eyelid Function and Signs Associated with Dry Eye in Subjects Suffering from Meibomian Gland Dysfunction and Control Subjects Using the OPI 2....
  Welch D, Contractor M, Abelson MB, Lane K, Ousler III GW., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Validation of the Enhanced Controlled Adverse Environment II.
  Ousler III GW, Johnston P, Welch D, Lane K, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Relationship Between Blink Pattern and Level of Ocular Surface Exposure in a Dry Eye Population.
  Lafond A, Lane K, Ousler III GW,Shapiro A, Angjeli E, Breton S, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Inter-Blink Interval Patterns in Dry Eye and Normal Subjects.
  Johnston P, Rodriguez J, Lane K, Ousler III GW, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Tear Film Dynamics Associated with Squeeze Blink in Dry Eye Subjects.
  Rodriguez J, Lane K, Angjeli E, Breton S, Ousler III GW, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Evaluation of Systane Balance for Normalization of Blink Patterns in a Dry Eye Population.
  Contractor M, Griffin J, Lane K, Ousler III GW, Angjeli E, Breton S, Abelson R, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Evaluation of Systane Balance for Effect on Area of Ocular Protection, Tear Film Break Up Time, and Interblink Interval in a Population of Dry Eye Subjects.
  Griffin J, Lane K, Ousler III, GW, Angjeli E, Breton S, Abelson R, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Development of a Videography-based Objective Eyelid Edema Scale.
  Angjeli E, Breton S, Lane K, Gomes P, Welch D, Torkildsen G, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2011
• Time to reflext tearing in response to chemical nasolacrimal stimulus in dry eye subjects versus normals.
  Maffei CJ, Ousler III GW, Welch DL, Curwen SJ, Prifogle E, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Correlation between blink rate, tear film corneal protection, and corneal staining.
  Rodriguez J, Angjeli E, Lane KJ, White R, Breton S, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Evaluation of Enhanced OPI; Using computerized video tracking of tear film break up for evaluation of tear film stability.
  Angjeli E, Rodriguez J, Lane KJ, Abelson MB, Ousler III GW., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Blink patterns in normal and dry eye subjects; Beyond blink rate.
  White R, Rodriguez J, Lane KJ, Johnston P, Angjeli E, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Enhanced precision of the Controlled Adverse Environment (CAE) system.
  Ousler III GW, Abelson MB, Welch DL., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Development of a redness scale for morning eye congestion.
  Breton S, Lane KJ, Gomes PJ, Shapiro A, Ousler III GW, Welch D, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Comparative assessment of murine allergic conjunctivitis model variations for efficient pre-clinical screening.
  Crawford KS, Gaines P, Breton SL, Chim HB, Lane KJ, Abelson MB., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Rhinorrhea reduction using bepreve ophthalmic solution 1.5% in a clinical model of allergic conjunctivitis: An analysis of pooled data from two phase 3 conjunctival al...
  Gow JA, Williams JI, Gomes PJ, Abelson MB, McNamara TR., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Perennial allergen skin sensitivity as a predictor of seasonal allergic rhinoconjunctivitis severity.
  Gomes P, Abelson MB, Mandell K., Association for Research in Vision and Ophthalmology Meeting, 5/2010
• Production of acute and late-phase response in allergic rhinitis in an Allergen BioCube.
  Abelson MB, Gomes P, Chaturvedi R., American Academy of Allergy, Asthma & Immunology Meeting., 2/2010
• Bepreve 1.5% reduces rhinorrhea for at least 16 hours: An integrated analysis of two phase 3 Conjunctival Allergen Challenge (CAC) clinical trials.
  McNamara TR, Williams JI, Gow JA, Gomes PJ, Abelson M., American Academy of Alelrgy, Asthma & Immunology Meeting., 2/2010
• Bepreve 1.5% reduces nasal congestion for at least 16 hours: an analysis of integrated data from two phase 3 Conjunctival Alelrgen Challenge (CAC) clinical Trials.
  Gow JA, William JI, McNamara TR, Gomes PJ, Abelson MB., American Academy of Allergy, Asthma & Immunology Meeting., 2/2010
• Bepotastine besilate ophthalmic solution 1.0% rapidly reduces conjunctival hyperemia in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis.
  Gow JA, Torkildsen GL, Williams JI, Gomes PJ, Abelson MB, McNamara TR., Association for Research in Vision and Ophthalmology Meeting, 5/2009
• The safety of the anti-histamine bepotastine besilate ophthalmic solution in a healthy pediatric population from 10 to seventeen years of age.
  Protzko EE, Williams JI, Gow JA, Gomes PJ, Abelson MB, McNamara TR., Association for Research in Vision and Ophthalmology Meeting, 5/2009
• Bepotastine besilate ophthalmic solution 1.5% reduces tearing at 8 hours following dosing in a multi-site clinical trial using the Conjunnctival Allergen Challenge (CA...
  Kurata FK, Macejko TT, Meier EJ, Bergmann MT, EB McLaurin, Williams JI, Gow JA, Abelson MB, McNamara TR., Association for Research in Vision and Ophthalmology Meeting, 5/2009
• Join now to see all

Other

• Delivering a Rocky Mountain ARVO 
  Abelson MB, Ora Staff.
  Review of Ophthalmology 22(7):56-58 - 7/1/2015
• The Secrets of Ocular Microbiomes. 
  Abelson MB, Lane K, Slocum C.
  Review of Ophthalmology 2015; 22(6)44-46 - 6/1/2015
• A Stepwise Approach to Acute Dry Eye. 
  Abelson MB, Smith L.
  Review of Ophthalmology 2015; 22(5):54-58, 97. - 5/1/2015
• Hopes and Hurdles for Stem Cell Therapy. 
  Abelson MB, McLaughlin JM.
  Review of Ophthalmology 2015; 22(4):74-77. - 4/1/2015
• Sampling New Targets for Allergy Therapy. 
  Abelson MB, Gelfman C, McLaughlin J.
  Review of Ophthalmology 2015; 22(3):66-68. - 3/1/2015
• Putting Your Contacts to Work. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2015; 22(2):56-58. - 2/1/2015
• Two Decades in Translation. 
  Abelson MB, Smith L, McLaughlin J.
  Review of Ophthalmology 2015; 22(1):52-55. - 1/1/2015
• 3,500 Years of Artificial Tears. 
  Abelson MB, Lafond A.
  Review of Ophthalmology 2014; 21(12):44-7. - 12/1/2014
• The Other Side of the Cornea. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(11):58-60. - 11/1/2014
• The Colors of Ocular Health. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(10):76-8. - 10/1/2014
• Thoughts on Healing The Wounded Cornea. 
  Abelson MB , McLaughlin J.
  Review of Ophthalmology 2014; 21(9):52-4. - 9/1/2014
• A Close Look at Pseudoexfoliation. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(8):52-5. - 8/1/2014
• ARVO Comes to the City of Magic. 
  Abelson MB, Ora Staff.
  Review of Ophthalmology 2014; 21(7):42-4, 47 - 7/1/2014
• Resistance Fighters: An Antibiotics Update. 
  Abelson MB, Shapiro A, McLaughlin J.
  Review of Ophthalmology 2014; 21(6):54-6. - 6/1/2014
• Innate Immunity: A Question of Balance. 
  Abelson MB, Gamache D, McLaughlin J.
  Review of Ophthalmology 2014; 21(5): 70-1, 73, 75, 90. - 5/1/2014
• A Recipe for Better Patient Compliance 
  Abelson MB, Stein L
  Review of Ophthalmology 2014; 21(4):70-2, 74-5 - 4/1/2014
• Fight Fire with Fire with Immunotherapy. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(3):62-64 - 3/1/2014
• Wise Choices for Ocular Diagnoses. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(2):50-52. - 2/1/2014
• Systemic Rxs and Ocular AEs. 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2014; 21(1):46-48. - 1/1/2014
• Cool Opportunities to Modulate Nociception. 
  Abelson MB, Gamache D.
  Review of Ophthalmology 2013; 20(12):48-50. - 12/15/2013
• Reading is Fundamental. 
  Abelson MB, Smith LM.
  Review of Ophthalmology 2013;20(11):110-112. - 11/1/2013
• The Modern Wisdom of Clinical Models 
  Abelson MB, Smith LM
  Review of Ophthalmology 2013; 20(10):62-65. - 10/1/2013
• A Street-Level Look at Urban Allergy. 
  Abelson MB, Gamache DA.
  Review of Ophthalmology 2013;20(9):50-53. - 9/1/2013
• Acupuncture: A Dry-Eye Therapy? 
  Abelson MB, McLaughlin J.
  Review of Ophthalmology 2013;20(8):58-63. - 8/1/2013
• ARVO Goes to The Emerald City. 
  Abelson MB, Ora Staff.
  Review of Ophthalmology 2013;20(7):50-55. - 7/1/2013
• Join now to see all